BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 82 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,678,184 | -12.7% | 1,573,781 | -0.5% | 1.70% | -8.6% |
| Q2 2023 | $25,977,770 | -1.1% | 1,582,081 | +0.6% | 1.86% | +0.7% |
| Q1 2023 | $26,271,896 | +12.4% | 1,572,226 | +3.8% | 1.85% | +15.2% |
| Q4 2022 | $23,382,082 | +51.2% | 1,515,365 | +46.3% | 1.60% | +34.2% |
| Q3 2022 | $15,463,000 | +12.6% | 1,035,676 | +23.9% | 1.20% | +27.6% |
| Q2 2022 | $13,737,000 | +91.3% | 836,082 | +133.5% | 0.94% | +122.6% |
| Q1 2022 | $7,182,000 | +19.5% | 358,024 | +51.0% | 0.42% | +31.6% |
| Q4 2021 | $6,012,000 | -0.4% | 237,077 | +6.0% | 0.32% | +5.6% |
| Q3 2021 | $6,035,000 | -38.2% | 223,667 | -33.7% | 0.30% | -35.4% |
| Q2 2021 | $9,761,000 | -12.4% | 337,533 | -20.4% | 0.47% | -12.8% |
| Q1 2021 | $11,149,000 | – | 423,925 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saba Capital Management, L.P. | 8,347,664 | $120,289,838 | 2.89% |
| Quantedge Capital Pte Ltd | 254,226 | $3,663,397 | 2.00% |
| 1607 Capital Partners, LLC | 1,573,781 | $22,678,184 | 1.70% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 1,684,864 | $24,278,890 | 1.26% |
| EPIQ PARTNERS, LLC | 103,000 | $1,484,231 | 1.12% |
| Almitas Capital LLC | 104,194 | $1,501,436 | 0.72% |
| Thomas J. Herzfeld Advisors, Inc. | 103,500 | $1,491,435 | 0.58% |
| Matisse Capital | 51,296 | $739,175 | 0.52% |
| Atlas Wealth LLC | 176,669 | $2,545,800 | 0.48% |
| Karpus Management, Inc. | 958,125 | $13,806,581 | 0.46% |